Table of Contents

2019-2024 Global Sickle Cell Anemia Therapeutics Market Report (Status and Outlook)

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Sickle Cell Anemia Therapeutics Market Size 2014-2024
2.1.2 Sickle Cell Anemia Therapeutics Market Size CAGR by Region
2.2 Sickle Cell Anemia Therapeutics Segment by Type
2.2.1 Blood Transfusion
2.2.2 Pharmacotherapy
2.2.3 Bone Marrow Transplant
2.3 Sickle Cell Anemia Therapeutics Market Size by Type
2.3.1 Global Sickle Cell Anemia Therapeutics Market Size Market Share by Type (2014-2019)
2.3.2 Global Sickle Cell Anemia Therapeutics Market Size Growth Rate by Type (2014-2019)
2.4 Sickle Cell Anemia Therapeutics Segment by Application
2.4.1 Child
2.4.2 Adult
2.5 Sickle Cell Anemia Therapeutics Market Size by Application
2.5.1 Global Sickle Cell Anemia Therapeutics Market Size Market Share by Application (2014-2019)
2.5.2 Global Sickle Cell Anemia Therapeutics Market Size Growth Rate by Application (2014-2019)

3 Global Sickle Cell Anemia Therapeutics by Players
3.1 Global Sickle Cell Anemia Therapeutics Market Size Market Share by Players
3.1.1 Global Sickle Cell Anemia Therapeutics Market Size by Players (2017-2019)
3.1.2 Global Sickle Cell Anemia Therapeutics Market Size Market Share by Players (2017-2019)
3.2 Global Sickle Cell Anemia Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Sickle Cell Anemia Therapeutics by Regions
4.1 Sickle Cell Anemia Therapeutics Market Size by Regions
4.2 Americas Sickle Cell Anemia Therapeutics Market Size Growth
4.3 APAC Sickle Cell Anemia Therapeutics Market Size Growth
4.4 Europe Sickle Cell Anemia Therapeutics Market Size Growth
4.5 Middle East & Africa Sickle Cell Anemia Therapeutics Market Size Growth

5 Americas
5.1 Americas Sickle Cell Anemia Therapeutics Market Size by Countries
5.2 Americas Sickle Cell Anemia Therapeutics Market Size by Type
5.3 Americas Sickle Cell Anemia Therapeutics Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Sickle Cell Anemia Therapeutics Market Size by Countries
6.2 APAC Sickle Cell Anemia Therapeutics Market Size by Type
6.3 APAC Sickle Cell Anemia Therapeutics Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Sickle Cell Anemia Therapeutics by Countries
7.2 Europe Sickle Cell Anemia Therapeutics Market Size by Type
7.3 Europe Sickle Cell Anemia Therapeutics Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Sickle Cell Anemia Therapeutics by Countries
8.2 Middle East & Africa Sickle Cell Anemia Therapeutics Market Size by Type
8.3 Middle East & Africa Sickle Cell Anemia Therapeutics Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Sickle Cell Anemia Therapeutics Market Forecast
10.1 Global Sickle Cell Anemia Therapeutics Market Size Forecast (2019-2024)
10.2 Global Sickle Cell Anemia Therapeutics Forecast by Regions
10.2.1 Global Sickle Cell Anemia Therapeutics Forecast by Regions (2019-2024)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Sickle Cell Anemia Therapeutics Forecast by Type
10.8 Global Sickle Cell Anemia Therapeutics Forecast by Application

11 Key Players Analysis
11.1 Emmaus Medical
11.1.1 Company Details
11.1.2 Sickle Cell Anemia Therapeutics Product Offered
11.1.3 Emmaus Medical Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
11.1.4 Main Business Overview
11.1.5 Emmaus Medical News
11.2 Addmedica
11.2.1 Company Details
11.2.2 Sickle Cell Anemia Therapeutics Product Offered
11.2.3 Addmedica Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
11.2.4 Main Business Overview
11.2.5 Addmedica News
11.3 Gamida Cell
11.3.1 Company Details
11.3.2 Sickle Cell Anemia Therapeutics Product Offered
11.3.3 Gamida Cell Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
11.3.4 Main Business Overview
11.3.5 Gamida Cell News
11.4 GlycoMimetics
11.4.1 Company Details
11.4.2 Sickle Cell Anemia Therapeutics Product Offered
11.4.3 GlycoMimetics Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
11.4.4 Main Business Overview
11.4.5 GlycoMimetics News
11.5 Pfizer
11.5.1 Company Details
11.5.2 Sickle Cell Anemia Therapeutics Product Offered
11.5.3 Pfizer Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
11.5.4 Main Business Overview
11.5.5 Pfizer News
11.6 Novartis
11.6.1 Company Details
11.6.2 Sickle Cell Anemia Therapeutics Product Offered
11.6.3 Novartis Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
11.6.4 Main Business Overview
11.6.5 Novartis News
11.7 Global Blood Therapeutics
11.7.1 Company Details
11.7.2 Sickle Cell Anemia Therapeutics Product Offered
11.7.3 Global Blood Therapeutics Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
11.7.4 Main Business Overview
11.7.5 Global Blood Therapeutics News
11.8 Micelle BioPharma
11.8.1 Company Details
11.8.2 Sickle Cell Anemia Therapeutics Product Offered
11.8.3 Micelle BioPharma Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
11.8.4 Main Business Overview
11.8.5 Micelle BioPharma News
11.9 Bluebird Bio
11.9.1 Company Details
11.9.2 Sickle Cell Anemia Therapeutics Product Offered
11.9.3 Bluebird Bio Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
11.9.4 Main Business Overview
11.9.5 Bluebird Bio News
11.10 Prolong Pharmaceuticals
11.10.1 Company Details
11.10.2 Sickle Cell Anemia Therapeutics Product Offered
11.10.3 Prolong Pharmaceuticals Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
11.10.4 Main Business Overview
11.10.5 Prolong Pharmaceuticals News
11.11 Modus Therapeutics
11.12 Sangamo Biosciences
11.13 Bioverativ
11.14 Imara
11.15 Ironwood Pharmaceuticals

12 Research Findings and Conclusion